CSIMarket


Integra Lifesciences Holdings Corp  (IART)
Other Ticker:  
 

Integra Lifesciences Holdings Corp

IART's Fundamental analysis








Integra Lifesciences Holdings's sales fell by -0.25 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 1463

Medical Equipment & Supplies industry recorded growth of revenues by 6.74 %

Integra Lifesciences Holdings's net profit deacreased by -62.54 % in IV. Quarter 2023 year on year, to $20 millions.

More on IART's Growth


Integra Lifesciences Holdings
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Integra Lifesciences Holdings realized cash outflow of $ -2.24per share in trailing twelve-month period.
Company
40.43
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.77.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.46.


More on IART's Valuation
 
 Total Debt (Millions $) 1,410
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 342,572
 Net Income/Employee (TTM) $ 15,054
 Receivable Turnover (TTM) 6
 Tangible Book Value (Per Share $) -6.64

Integra Lifesciences Holdings
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Integra Lifesciences Holdings realized cash outflow of $ -2.24per share in trailing twelve-month period.
Company
40.43
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.77.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.46.

Integra Lifesciences Holdings Price to Book Ratio is at 1.71 higher than Indusry Avg. of -550.26, and higher than S&P 500 Avg. of 0.01

More on IART's Valuation

  Market Capitalization (Millions $) 2,722
  Shares Outstanding (Millions) 81
  Employees 4,500
  Revenues (TTM) (Millions $) 1,542
  Net Income (TTM) (Millions $) 68
  Cash Flow (TTM) (Millions $) -180
  Capital Exp. (TTM) (Millions $) -67
  Total Debt (Millions $) 1,410
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 342,572
  Net Income/Employee(TTM) $ 15,054
  Receivable Turnover Ratio (TTM) 6
  Tangible Book Value (Per Share $) -6.64

  Market Capitalization (Millions $) 2,722
  Shares Outstanding (Millions) 81
  Employees 4,500
  Revenues (TTM) (Millions $) 1,542
  Net Income (TTM) (Millions $) 68
  Cash Flow (TTM) (Millions $) -180
  Capital Exp. (TTM) (Millions $) -67


    IART's Profitability Comparisons
Integra Lifesciences Holdings achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 9.08 % from 6.95 % in III. Quarter.

Integra Lifesciences Holdings net profit margin of 5 % is currently ranking no. 46 in Medical Equipment & Supplies industry, ranking no. 124 in Healthcare sector and number 1432 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.74
  Total Debt to Equity (MRQ) 0.89
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.42
  Inventory Turnover Ratio (TTM) 1.8



Integra Lifesciences Holdings achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 9.08 % from 6.95 % in III. Quarter.

Integra Lifesciences Holdings net profit margin of 5 % is currently ranking no. 46 in Medical Equipment & Supplies industry, ranking no. 124 in Healthcare sector and number 1432 in S&P 500.

More on IART's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com